By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ExThera Medical 

Stockholm      Sweden
Phone: n/a Fax: n/a


Medical Device

Company News
FDA Grants ExThera Medical’s Seraph 100 Blood Filter Expedited Access Pathway (EAP) Designation 8/30/2017 7:32:45 AM
DARPA Funds ExThera Medicall’s "Seraph" Blood Filter For Pre-Clinical Testing 7/10/2017 10:57:29 AM
ExThera MedicalCloses Financing Led By Fresenius Medical Care (FMS) Ventures To Support Commercialization Of Innovative Technology To Remove Pathogens From Whole Blood 6/2/2016 2:15:43 PM
ExThera Medical Achieves Promising Preliminary Safety And Efficacy Results In A Large-Animal Model 1/11/2016 10:52:03 AM
ExThera Medical Presents Results Of Cytomegalovirus (CMV) Binding Study 1/28/2015 8:16:44 AM
ExThera Medical Joins Battelle Team To Work On DARPA’s DLT Program, Aimed At Developing A Medical Device For Treating Sepsis 1/7/2015 10:51:34 AM
ExThera Medical Publishes Results Of "CRE Superbug" Binding Study: A Device-Based Therapy For Drug-resistant Bacterial Infections Is Now Possible 12/4/2014 9:24:52 AM
ExThera Medical Posts $3.75 Million First Closing Of Its $7 Million Convertible Note Offering 10/6/2014 10:52:35 AM
ExThera Medical Appoints John W. Feik To Its Board Of Directors 9/12/2014 10:09:47 AM
U.S. Patent No. 8,758,286 Issued To ExThera Medical, Whose Seraph® Technology Is Designed To Combat Drug-Resistant "Superbugs" 6/24/2014 10:37:55 AM